Insider Trading & Ownership - BERMAN ROBERT ANDREW

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BERMAN ROBERT ANDREW
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-27
Purchase
2022-06-28
4:05 pm
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
Chief Executive Officer
2,500$3.8$9,500210,236
(Direct)
View
2021-11-19
Purchase
2021-11-19
5:27 pm
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
CEO
2,000$7.43$14,8607,736
(Direct)
View
2021-11-16
Purchase
2021-11-18
4:24 pm
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
CEO
2,000$7.87$15,7405,736
(Direct)
View
2021-05-18
Purchase
2021-05-19
8:20 pm
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
Chief Executive Officer
3,000$5.47$16,4103,736
(Direct)
View
2019-03-12
Purchase(A)
2019-04-17
6:47 pm
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
Chief Executive Officer
18,382$1.36$25,00018,382
(Direct)
View
2019-03-12
Purchase
2019-03-14
6:52 pm
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
Chief Executive Officer
21,740$1.15$25,00121,740
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-05
Option Award
2023-12-07
5:05 pm
N/A
2033-12-05
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
Chief Executive Officer
300,000$0300,000
(Direct)
View
2021-11-30
Option Award
2021-12-02
6:27 pm
N/A
2031-11-30
enVVeno Medical CorpNVNOBERMAN ROBERT ANDREW
Chief Executive Officer
549,781$0557,517
(Direct)
View
2021-02-18
Option Award
2021-02-22
9:56 pm
N/A
2031-02-18
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
Chief Executive Officer
838,000$0838,000
(Direct)
View
2020-07-18
Option Award
2020-07-21
9:55 pm
N/A
2030-07-18
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
CEO
1,080,207$01,080,207
(Direct)
View
2020-07-18
Other
2020-07-21
9:55 pm
2018-04-26
2028-04-26
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
CEO
1,080,207$01,080,207
(Direct)
View
2020-07-18
Option Award
2020-07-21
9:55 pm
N/A
2030-07-18
Hancock Jaffe Laboratories Inc.HJLIBERMAN ROBERT ANDREW
CEO
1,000,000$01,000,000
(Direct)
View
(A) Indicate amendment filing.